Allianz (ALV) Given a €220.00 Price Target at UBS Group

Share on StockTwits

UBS Group set a €220.00 ($255.81) price objective on Allianz (FRA:ALV) in a research note published on Friday morning, www.boersen-zeitung.de reports. The firm currently has a buy rating on the stock.

Several other equities analysts have also recently weighed in on the company. Barclays set a €210.00 ($244.19) price objective on Allianz and gave the company a neutral rating in a research note on Friday, September 7th. JPMorgan Chase & Co. set a €219.00 ($254.65) target price on Allianz and gave the company a buy rating in a research report on Monday, October 1st. BNP Paribas set a €205.00 ($238.37) target price on Allianz and gave the company a neutral rating in a research report on Tuesday, September 11th. Deutsche Bank set a €220.00 ($255.81) target price on Allianz and gave the company a buy rating in a research report on Tuesday, October 2nd. Finally, equinet set a €200.00 ($232.56) target price on Allianz and gave the company a neutral rating in a research report on Friday, July 13th. Thirteen equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Allianz presently has an average rating of Buy and a consensus price target of €210.54 ($244.81).

FRA:ALV traded up €4.98 ($5.79) during trading hours on Friday, hitting €192.00 ($223.26). 2,168,274 shares of the company traded hands. Allianz has a one year low of €167.30 ($194.53) and a one year high of €206.80 ($240.47).

Allianz Company Profile

Allianz SE, together with its subsidiaries, provides property-casualty insurance, life/health insurance, and asset management products and services worldwide. The company's Property-Casualty segment offers various insurance products, including motor liability and own damage, accident, general liability, fire and property, legal expense, credit, and travel insurance products to private and corporate customers.

Recommended Story: Benefits of owning preferred stock

Analyst Recommendations for Allianz (FRA:ALV)

Receive News & Ratings for Allianz Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allianz and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.